Patients can control and reduce their risk for contracting colon cancer and colitis by maintaining a balance of two major isoforms, according to findings published in the journal eLife.
As medications for hepatitis C become more widely used, studies are being done to see how effective these treatments are when used in combination.
Mothers’ inflammatory bowel disease (IBD) therapies may impact their newborns, according to findings published in Gastroenterology.
Pain medications can often cause side effects such as dizziness and sleepiness; but little do pregnant women know that they could be at risk for birth defects when taking pregabalin.
Psoriatic arthritis patients receiving anti-tumor necrosis factor alpha can achieve remission, researchers in Ireland report.
The overwhelming experience of preparing for colonoscopies may no longer have to be tolerated on an empty stomach.
Studying the use of targeted medicines in psychiatry is still new but early studies have shown that this could be a viable treatment option in the future for some patients in need.
In the field of oncology the use of targeted medications is becoming more commonplace to address various conditions. Research is being done in other areas of medicine, including psychiatry to see if there is more that can be done to address this patient population as well.
The development of new medications for any condition requires attention to detail in a number of areas, especially safety and efficacy. A recent drug developed for irritable bowel syndrome (IBS) looked to be effective in both areas prior to its approval.